Suchergebnisse - "Grikscheit, Katharina"

PubPharm (38)

11

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes

enthalten in: Science immunology | 2022

von Quandt, J. | Muik, A. | Salisch, N. | +15

CommentIn: Sci Immunol. 2022 Aug 26;7(74):eabq5901. - PMID 35653497

12

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

enthalten in: EBioMedicine | 2022

von Wilhelm, A. | Widera, M. | Grikscheit, K. | +12

13

Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination

enthalten in: Vaccines | 2022

von Grikscheit, K. | Rabenau, H. | Ghodratian, Z. | +7

14

Characterization of antibody and T-cell response after second booster vaccination

enthalten in: ResearchSquare.com | 2022

von Grikscheit, K. | Rabenau, H. | Ghodatrian, Z. | +7

15

Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation

enthalten in: bioRxiv.org | 2022

von Quandt, J. | Muik, A. | Salisch, N. | +15

16

Low But Recoverable Markers of Humoral Immune Response to BNT162b2 in Elderly LTCF Residents Five to Seven Months After Two-Dose Vaccination

enthalten in: Frontiers in aging | 2022

von Delbrück, M. | Hoehl, S. | Toptan, T. | +5

17

Characterization of the humoral immune response to BNT162b2 in elderly residents of long-term care facilities five to seven months after vaccination

enthalten in: bioRxiv.org | 2021

von Delbrück, M. | Hoehl, S. | Toptan, T. | +5

18

Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies

Erschienen: Frankfurt am Main, Universitätsbibliothek Johann Christian Senckenberg, 2021

von Wilhelm, A. | Widera, M. | Grikscheit, K. | +10

19

Ebola Virus Nucleocapsid-Like Structures Utilize Arp2/3 Signaling for Intracellular Long-Distance Transport

enthalten in: Cells | 2020

von Grikscheit, K. | Dolnik, O. | Takamatsu, Y. | +2

20

TTU 01.802 - FP2016: Emergency vaccines : Schlussbericht zum DZIF-Vorhaben : koordinierende Einrichtung: Philipps-Universität Marburg ; beteiligte Einrichtungen: Ludwig-Maximilians Universität München, Philipps-Universität Marburg, Paul-Ehrlich-Institut ; Autor(en): Philipps-Universität Marburg: Prof. Dr. Becker, Stephan; Dr. Matrosovich, Mikhail; Dr. Grikscheit, Katharina; Paul-Ehrlich-Institut: Dr. Mühlebach, Michael; Ludwig-Maximilians Universität München: Prof. Dr. Sutter, Gerd

Erschienen: [Marburg], Philipps-Universität Marburg, Mai 2019

von Becker, S. | Matrosovich, M. | Grikscheit, K. | +2